Salloway, S., Sperling, R., Gilman, S., Fox, N. C., Blennow, K., Raskind, M., . . . Grundman, M. (2009). A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. American Academy of Neurology.
Citação norma ChicagoSalloway, S., et al. A Phase 2 Multiple Ascending Dose Trial of Bapineuzumab in Mild to Moderate Alzheimer Disease. American Academy of Neurology, 2009.
Citação norma MLASalloway, S., et al. A Phase 2 Multiple Ascending Dose Trial of Bapineuzumab in Mild to Moderate Alzheimer Disease. American Academy of Neurology, 2009.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.